Defective function of langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4842-4851

  Ishida, Tadao ^a   Oyama, Tsunehiro ^a   Carbone, David P ^a   Gabrilovich, Dmitry I ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; NEUTRALIZING ANTIBODY; VASCULOTROPIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BONE MARROW; CELL COUNT; CELL MOVEMENT; CHEMOTACTIC FACTORS; DENDRITIC CELLS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HEMATOPOIESIS; IMMUNIZATION, PASSIVE; IMMUNOLOGIC DEFICIENCY SYNDROMES; LANGERHANS CELLS; LYMPH NODES; LYMPHOKINES; MICE; MICE, INBRED A; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; RADIATION CHIMERA; SARCOMA, EXPERIMENTAL; SKIN; SPECIFIC PATHOGEN-FREE ORGANISMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032211082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Romani, N., and G. Schuler. 1992. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin. Immunopathol. 13:265.
2. Steinman, R., L. Hoffman, and M. Pope. 1995. Maturation and migration of cutaneous dendritic cells. J. Invest. Dermatol. 105:2S.
3. Gabrilovich, D., F. Ciernik, and D. P. Carbone. 1996. Denaritic cells in anti-tumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 170:101.
4. Gabrilovich, D. I., J. Corak, I. F. Ciernik, D. Kavanaugh, and D. P. Carbone. 1997. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:483.
5. Chaux, P., M. Moutet, J. Faivre, F. Martin, and M. M. 1996. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest. 74:975.
6. Chaux, P., N. Favre, M. Martin, and M. F. 1997. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 72:619.
7. Nestle, F. O., G. Burg, J. Fah, T. Wrone-Smith, and B. J. Nickoloff. 1997. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150:641.
8. Macatonia, S., S. Knight, A. J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: functional and morphological studies. J. Exp. Med. 166:1654.
9. Hill, S., A. J. Edwards, I. Kimber, and S. C. Knight. 1990. Systemic migration of dendritic cells during contact sensitization. Immunology 71:277.
10. Gabrilovich, D. I., S. Nadaf, J. Corak, J. A. Berzofsky, and D. P. Carbone. 1996. Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell. Immunol. 170:111.
11. + cytotoxic T-cells. Cancer Res. 53:3257.
12. Noguchi, Y., E. C. Richards, Y.-T. Chen, and L. Old. 1995. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci. USA 92:2219.
13. Gabrilovich, D. I., G. M. Woods, S. Patterson, J. J. Harvey, and S. C. Knight. 1994. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology 82:82.
14. Baker, K. W., and J. E. J. Habowsky. 1983. EDTA separation and ATPase Langerhans cell staining in the mouse epidermis. J. Invest. Dermatol 80:104.
15. Muller, H. K., G. M. Halliday, and B. Knight. 1985. Carcinogen induced depletion of cutaneous Langerhans cells. Br. J. Cancer 52:81.
16. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1096.
17. Bergfelt L., A. Emilson, M. Lindberg, and A. Scheynius. 1994. Quantitative and 3-dimensional analysis of Langerhans cells in basal cell carcinoma: a comparative study using light microscopy and confocal laser scanning microscopy. Br. J. Dermatol. 130:273.
18. Townsend, W., M. Gorrell, and R. Mayer. 1997. Langerhans cells in the development of skin cancer: a qualitative and quantitative comparison of cell markers in normal, acanthotic and neoplastic ovine skin. Pathology 29:42.
19. Toriyama, K., D. R. Wen, E. Paul, and A. J. Cochra, 1993. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J. Invest. Dermatol. 100:269S.
20. Tas, M., P. Simons, F. Balm, and H. Drexhage. 1993. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunel. Immunother. 36:108.
21. Enk, A. H., H. Jonuleit, J. Saloga, and J. Knop. 1997. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 73:309.
22. Knight, S. C., J. Krejci, M. Malkovsky, V. Colizzi, A. Gautam, and G. L. Asherson. 1985. The role of dendritic cells in initiation of immune response to contact sensitisers. I. In vivo exposure to antigen. Cell. Immunol. 94:427.
23. Gabrilovich, D. I., H. T. Cunningham, and D. P. Carbone. 1997. IL-12 and mutant p53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer. J. Immunother. 19:414.
24. + T cells. Proc. Natl. Acad. Sci. USA 91:3171.
25. Becker, Y. 1992. Anticancer role of dendritic cells (DC) in human and experimental cancers: a review. Anticancer Res. 12:511.
26. Katz, S. L., K. Tamaki, and D. H. Sach. 1979. Epidermal Langerhans cells are derived from cell originating from bone marrow. Nature 282:324.
27. Holt, P. G., S. Haining, D. J. Nelson, and J. D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153:256.
28. Caux, C., C. Massacrier, B. Vanbervliet, C. Barthelemy, Y. J. Liu, and J. Banchereau. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6:1177.
29. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:2390.
30. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J. Immunol. 150:3755.
31. Beissert, S., J. Hosoi, S. Grabbe, A. Asahina, and R. D. Granstein. 1995. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154:1280.
32. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
33. Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems. 1997. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 27:1848.
34. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229.
35. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
36. Fortis, C., M. Foppoli, L. Gianotti, L. Galli, G. Citterio, G. Consogno, O. Gentilini, and M. Braga. 1996. Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett. 104:1.
37. Lissoni, P., F. Rovelli, E. Tisi, F. Brivio, A. Ardizzoia, S. Barni, G. Tancini, M. Saudelli, E. Cesana, and M. G. Vigano. 1995. Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors. J. Biol. Regul. Homeost. Agents. 9:146.
38. Nakagomi, H., P. Pisa, E. Pisa, Y. Yamamoto, E. Halapi, K. Backlin, C. Juhlin, and R. Kiessling. 1995. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int. J. Cancer 63:366.
39. Oyama, T., S. Ran, T. Ishida, S. Nadaf, L. Kerr. D. Carbone, and D. I. Gabrilovich. 1998. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kB activation in hemopoietic progenitor cells. J. Immunol. 160:1224.
40. Ferrara, N., and D. T. Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4.
41. Borgstrom, P., K. J. Hillan, P. Sriramarao, and N. Ferrara. 1996. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56:4032.
42. Melnyk, O., M. A. Shuman, and K. J. Kim. 1996. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56:921.
43. Kim, K. J., B. Li, J. Winer. M. Armanini, N. Gilett, H. S. Fillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362.
44. Warren, R. S., H. Yuan, M. R. Matli, N. A. Gillett, and N. Ferrara. 1995. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95:1789.